Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

[Effect of doxorubicin on TRAIL resistance and TRAIL receptor expression in lymphoma cell line SNK-6 cells].

Zhang YC, Yang QP, Tang Y, Wang WY, Yu JB, Liu WP.

Zhonghua Zhong Liu Za Zhi. 2013 Sep;35(9):651-4. Chinese.

PMID:
24332050
2.

[Synergistic effect and its possible mechanisms of lidamycin in combination with TRAIL in NSCLC].

Yang J, Chen SZ.

Yao Xue Xue Bao. 2010 Oct;45(10):1247-53. Chinese.

PMID:
21348302
3.

[Study of molecular mechanism of doxorubicin enhancement of TRAIL, inducing apoptosis of myeloma cell line KM3].

Wang HF, Chen ZH, Sun CY, Hu Y.

Zhonghua Xue Ye Xue Za Zhi. 2007 Jan;28(1):30-2. Chinese.

PMID:
17649723
4.

Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.

Lee AL, Dhillon SH, Wang Y, Pervaiz S, Fan W, Yang YY.

Mol Biosyst. 2011 May;7(5):1512-22. doi: 10.1039/c0mb00266f. Epub 2011 Feb 24.

PMID:
21350763
5.

Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.

Cuello M, Ettenberg SA, Nau MM, Lipkowitz S.

Gynecol Oncol. 2001 Jun;81(3):380-90.

PMID:
11371126
6.

Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells.

Yoshida T, Zhang Y, Rivera Rosado LA, Zhang B.

Mol Cancer Res. 2009 Nov;7(11):1835-44. doi: 10.1158/1541-7786.MCR-09-0244. Epub 2009 Oct 20.

7.
8.

Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis.

Lacour S, Hammann A, Wotawa A, Corcos L, Solary E, Dimanche-Boitrel MT.

Cancer Res. 2001 Feb 15;61(4):1645-51.

9.

Aclarubicin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis through death receptor 5 upregulation.

Horinaka M, Yoshida T, Nakata S, Shiraishi T, Tomosugi M, Yoshikawa S, Wakada M, Sakai T.

Cancer Sci. 2012 Feb;103(2):282-7. doi: 10.1111/j.1349-7006.2011.02150.x. Epub 2011 Dec 13.

10.

Doxorubicin potentiates TRAIL cytotoxicity and apoptosis and can overcome TRAIL-resistance in rhabdomyosarcoma cells.

Komdeur R, Meijer C, Van Zweeden M, De Jong S, Wesseling J, Hoekstra HJ, van der Graaf WT.

Int J Oncol. 2004 Sep;25(3):677-84.

PMID:
15289869
11.
13.

[Cisplatin enhances TRAIL-induced apoptosis in gastric cancer cells through clustering death receptor 4 into lipid rafts].

Xu L, Qu XJ, Liu YP, Liu J, Zhang Y, Hou KZ, Jiang YH.

Zhonghua Zhong Liu Za Zhi. 2011 Jul;33(7):484-8. Chinese.

PMID:
22093622
14.

Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis.

Yasukochi A, Kawakubo T, Nakamura S, Yamamoto K.

Biol Chem. 2010 Aug;391(8):947-58. doi: 10.1515/BC.2010.087.

PMID:
20482316
15.

[Glycosylation inhibitor 2-deoxy-D-glucose sensitizes oral cancer cells to TRAIL-induced apoptosis].

Xu J, Huang Y, Li Y, Pu L, Xia F, Jiang C, Liu H, Jiang Z.

Nan Fang Yi Ke Da Xue Xue Bao. 2013 Apr;33(4):524-7. Chinese.

16.

Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells.

Festuccia C, Gravina GL, D'Alessandro AM, Millimaggi D, Di Rocco C, Dolo V, Ricevuto E, Vicentini C, Bologna M.

Int J Oncol. 2008 Aug;33(2):381-8.

PMID:
18636160
17.

Ex vivo purging of leukemia cells using tumor-necrosis-factor-related apoptosis-inducing ligand in hematopoietic stem cell transplantation.

Lee NS, Cheong HJ, Kim SJ, Kim SE, Kim CK, Lee KT, Park SK, Baick SH, Hong DS, Park HS, Won JH.

Leukemia. 2003 Jul;17(7):1375-83.

PMID:
12835727

Supplemental Content

Support Center